These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 6435321

  • 1. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
    Cserhalmi L, Assmann I, Glavanov M, Rev J, Kelecseńeyi Z.
    Z Gesamte Inn Med; 1984 Jul 15; 39(14):330-5. PubMed ID: 6435321
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T, Hess OM, Jenni R, Krayenbühl HP.
    Z Kardiol; 1983 Sep 15; 72(9):487-93. PubMed ID: 6415946
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil].
    Bouhour JB, Potiron M, Chiffoleau S, Lefévre M, Louvet S.
    Arch Mal Coeur Vaiss; 1987 Jan 15; 80(1):76-82. PubMed ID: 3107495
    [Abstract] [Full Text] [Related]

  • 10. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
    Kober G, Hopf R, Biamino G, Bubenheimer P, Förster K, Kuck KH, Hanrath P, von Olshausen KE, Schlepper M, Kaltenbach M.
    Z Kardiol; 1987 Jan 15; 76 Suppl 3():113-8. PubMed ID: 3324526
    [Abstract] [Full Text] [Related]

  • 11. Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.
    Landmark K, Sire S, Thaulow E, Amlie JP, Nitter-Hauge S.
    Br Heart J; 1982 Jul 15; 48(1):19-26. PubMed ID: 7200796
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
    Rosing DR, Idänpään-Heikkilä U, Maron BJ, Bonow RO, Epstein SE.
    Am J Cardiol; 1985 Jan 25; 55(3):185B-195B. PubMed ID: 3881913
    [Abstract] [Full Text] [Related]

  • 20. [Acute effects of propranolol on the abnormal diastolic hemodynamics of the left ventricle in hypertrophic cardiomyopathy (author's transl)].
    Koga Y, Akiyoski T, Nagae K, Mizobuchi H, Toshima H.
    Kokyu To Junkan; 1978 May 25; 26(5):473-6. PubMed ID: 351757
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.